PPP2R2B and breast cancer: Moreover, the Nomogram analysis unveiled that the expression level of PPP2R2B, serving as an independent predictive risk factor, provides a quantitative tool for healthcare professionals to assess the likelihood of progression-free survival at 1, 3, and 5 years for BC patients.